Enzyme-linked immunosorbent assay to detect urinary antibody against recombinant rKRP42 antigen made from Leishmania donovani for the diagnosis of visceral leishmaniasis

American Journal of Tropical Medicine and Hygiene

Volumn 79, Issue 4, 2008, Pages 599-604

  Islam, Mohammad Zahidul ^a   Itoh, Makoto ^a   Takagi, Hidekazu ^a   Islam, Anwar Ul ^b   Saifuddin Ekram, A R M ^c   Rahman, Ajijur ^b   Takesue, Atsuhide ^a   Hashiguchi, Yoshihisa ^d   Kimura, Eisaku ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF RAJSHAHI   (Bangladesh)

^c RAJSHAHI MEDICAL COLLEGE   (Bangladesh)

^d KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT ANTIGEN; RECOMBINANT RKRP42 ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LEISHMANIA DONOVANI; SENSITIVITY AND SPECIFICITY; URINALYSIS; VISCERAL LEISHMANIASIS;

LEISHMANIA DONOVANI;

EID: 53749089613     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2008.79.599     Document Type: Article

References (30)

1. Collin S, Davidson R, Ritmeijer K, Keus K, Melaku Y, Kipngetich S, Davies C, 2004. Conflict and kala-azar: determinants of adverse outcome of kala-azar among patients in Southern Sudan. Clin Infect Dis 38: 612-619.
2. Ahluwalia IB, Bern C, Costa C, Akter T, Chowdhury R, Ali M, Alam D, Kenah E, Amann J, Islam M, Wagatsuma Y, Haque R, Breiman RF, Maguire JH, 2003. Visceral leishmaniasis: consequences of a neglected disease in a Bangladeshi community. Am J Trop Med Hyg 69: 624-628.
3. World Health Organization, 2007. Global Plan to combat Ne glected Tropical Diseases, 2008-2015. Geneva, Switzerland: World Health Organization.
4. Zijlstra EE, Ali MS, el-Hassan AM, el-Toum IA, Satti M, Ghalib HW, Kager PA, 1992. Kala-azar: a comparative study of parasitological methods and the direct agglutination test in diagnosis. Trans R Soc Trop Med Hyg 86: 505-507.
5. Kaul P, Malla N, Kaur S, Mahajan RC, Ganguly NK, 2000. Evaluation of a 200-kDa amastigote-specific antigen of L. donovani by enzyme-linked immunosorbent assay (ELISA) for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg 94: 173-175.
6. Raj VS, Ghosh A, Dole VS, Madhubala R, Myler PJ, Stuart KD, 1999. Serodiagnosis of leishmaniasis with recombinant ORFF antigen. Am J Trop Med Hyg 61: 482-487.
7. Zijlstra EE, Daifalla NS, Kager PA, Khalil EAG, El-Hassan AM, Reed SG, Ghalib HW, 1998. rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infection. Clin Diagn Lab Immunol 5: 717-720.
8. Harith AE, Kolk AHJ, Kager PA, Leeuwenburg J, Muigai R, Kiugu S, Laarman JJ, 1986. A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis. Trans R Soc Trop Med Hyg 80: 583-587.
9. Harith AE, Kolk AHJ, Leeuwenburg J, Muigai R, Huigen E, Jelsma T, Kager PA, 1988. Improvement of a direct agglutination test for field studies of visceral leishmaniasis. J Clin Microbiol 26: 1321-1325.
10. Burns JM, Shreffler WG, Benson DR, Ghalib HW, Badaro R, Reed SG, 1993. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African American visceral leishmaniasis. Proc Natl Acad Sci USA 90: 775-779.
11. Maalej IA, Chenik M, Louzir H, Salah AB, Bahloul C, Amri F, Dellagi K, 2003. Comparative evaluation of ELISAs based on ten recombinant or purified leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am J Trop Med Hyg 68: 312-320.
12. Sundar S, Reed SG, Singh VP, Kumar PCK, Murray HW, 1998. Rapid accurate field diagnosis of Indian visceral leishmaniasis. Lancet 351: 563-565.
13. Sundar S, Pai K, Sahu M, Kumar V, Marray HW, 2002. Immunochromatographic strip-test detection of anti-K39 antibody in Indian visceral leishmaniasis. Ann Trop Med Parasitol 96: 19-23.
14. Bern C, Jha SN, Joshi AB, Thakur GD, Bista MB, 2000. Use of the recombinant K39 dipstick test and the direct agglutination test in a setting endemic for visceral leishmaniasis in Nepal. Am J Trop Med Hyg 63: 153-157.
15. Delgado O, Feliciangeli MD, Coraspe V, Silva S, Perez A, Arias J, 2001. Value of a dipstick based on recombinant rK39 antigen for differential diagnosis of American visceral leishmaniasis from other sympatric endemic diseases in Venezuela. Parasite 8: 355-357.
16. Jelinek T, Eichenlaub S, Löscher T, 1999. Sensitivity and specificity of a rapid immunochromatographic test for diagnosis of visceral leishmaniasis. Eur J Clin Mirobiol Infect Dis 18: 669-670.
17. Zijlstra EE, Nur Y, Desjeux P, Khalil E, El-Hassan AM, Groen J, 2001. Diagnosing visceral leishmaniasis with the recombinant K39 strip test: experience from the Sudan. Trop Med Int Health 6: 108-113.
18. Carvalho SF, Lemos EM, Corey R, Dietze R, 2003. Performance of recombinant K39 antigen in the diagnosis of Brazilian visceral leishmaniasis. Am J Trop Med Hyg 68: 321-324.
19. Takagi H, Islam MZ, Itoh M, Islam MAU, Ekram ARMS, Hussain SM, Hashiguchi Y, Kimura E, 2007. Production of recombinant kinesin-related protein of Leishmania donovani and its application in the serodiagnosis of visceral leishmaniasis. Am J Trop Med Hyg 76: 902-905.
20. Attar ZJ, Chance ML, el-Safi S, Carney J, Azazy A, El-Hadi M, Dourado C, Hommel M, 2001. Latex agglutination test for the detection of urinary antigens in visceral leishmaniasis. Acta Trop 78: 11-16.
21. Sarkari B, Chance M, Hommel M, 2002. Antigenuria in visceral leishmaniasis: detection and partial charecterisation of a carbohydrate antigen. Acta Trop 82: 339-348.
22. Islam MZ, Itoh M, Shamsuzzaman SM, Mirza R, Matin F, Ahmed I, Choudhury AKMS, Hossain MA, Qiu XG, Begam N, Furuya M, Leafasia JL, Hashiguchi Y, Kimura E, 2002. Diagnosis of visceral leishmaniasis by ELISA using urine samples. Clin Diagn Lab Immunol 9: 789-794.
23. Islam MZ, Itoh M, Mirza R, Ahmed I, Ekram ARMS, Sarder AH, Shamsuzzaman SM, Hashiguchi Y, Kimura E, 2004. Direct agglutination test with urine samples for the diagnosis of visceral leishmaniasis. Am J Trop Med Hyg 70: 78-82.
24. World Health Organization, 1996. Manual on Visceral Leishma niasis Control. Geneva, Switzerland: World Health Organization.
25. World Health Organization, 1984. Leishmaniasis. Geneva, Switzerland: World Health Organization.
26. Khalil EAG, Zijlstra EE, Kager PA, El Hassan MA, 2002. Epidemiology and clinical manifestations of Leishmania donovani infection in two villages in an endemic area in eastern Sudan. Trop Med Int Health 7: 35-44.
27. Singh S, Kumari V, Singh N, 2002. Predicting kala-azar disease manifestations in asymptomatic patients with latent Leishmania donovani infection by detection of antibody against recombinant K39 antigen. Clin Diagn Lab Immunol 9: 568-572.
28. Jha TK, Sundar S, Thakur CP, Backmann P, Karbwang J, Fischer C, Vos A, Berman J, 1999. Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med 341: 1795-1800.
29. Rijal S, Boelaert M, Regmi S, Karki BMS, Jacquet D, Singh R, Chance ML, Chappuis F, Hommel M, Desjeux P, Van der Stuyft P, Le Ray D, Koirala S, 2004. Evaluation of urinary antigen-based latex agglutination test in the diagnosis of kalaazar in eastern Nepal. Trop Med Int Health 9: 724-729.
30. Sundar S, Sing RK, Bimal SK, Gidwani K, Mishra A, Mauriya R, Singh SK, Manandar KD, Boelaert M, Rai M, 2007. Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study. Trop Med Int Health 12: 284-289.